Legal Opinion

Collier v. Bayer HealthCare Pharmaceuticals Inc.

District Court, D. Minnesota

Decided July 9, 2018No. 0:18-cv-01897Unknown

1Opinion

UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION IN RE: FLUOROQUINOLONE PRODUCTS LIABILITY LITIGATION MDL No. 2642 (SEE ATTACHED SCHEDULE) CONDITIONAL TRANSFER ORDER (CTO —128) On August 17, 2015, the Panel transferred 19 civil action(s) to the United States District Court for the District of Minnesota for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. See

122 F.Supp.3d 1378

(J.P.M.L. 2015). Since that time, 749 additional action(s) have been transferred to the District of Minnesota. With the consent of that court, all such actions have been assigned to…

2Cases cited1 opinion

  1. In re Fluoroquinolone Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2015

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API